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and it now appears likely that carbocaine, which has recently
been added to the list of local anaesthetic drugs, may well
replace lignocaine. A recent article in the Journa[3 describes
the advantages of this drug over lignocaine, and is well
worth the attention of those who make frequent use of local
anaesthetics.
Lignocaine, marketed as 'xylocaine' or 'xylotox', is, how-
ever, till the local anaesthetic drug in most common use in
this country at the present time, and deaths have occurred
recently from overdosage and the high concentration of
adrenaline being used. It i unfortunate that lignocaine for
injection purposes is usually supplied to hospitals in a 2%
solution plain, or in a 2 %solution with 1 : 80,000 adrenaline.
When a large amount of local anaesthetic is required for
infiltration purpose, e.g. for herniorrhaphy, amputation of
limbs, abdominal field blocks, etc., a 0·5 % concentration
of lignocaine is quite adequate. The concentration of adrena-
line should never exceed 1 : 200,000.
It is suggested that the following solution be prepared
for use when any large amount of lignocaine is being used:
Lignocaine 2% plain, 25 ml.; normal saline, 75 ml.; and
adrenaline, O· 5 ml., 1 : 1,000.
The above solution will contain 500 mg. of lignocaine
in a O' 5% solution and the concentration of adrenaline will
be 1 : 200,000. 500 mg. of lignocaine should not be exceeded,
and for the elderly and frail patient a smaller dose or a
more dilute concentration should be used.4
A small dose of thiopentone should always be immediately
available fOJ; intravenous administration if convulsions occur
and should be followed by oxygen given under pressure
from some simple apparatus.
I. Editorial (1950): s. Afr. Med. J., 24, 656.
2. Barton, J. D. M. (1951): Ibid., 25, 832.
3. Voss, T. J. v. (1960): Ibid., 34, 926.
4. Bryce-Smith, R. (1960): Brit. Med. l., 1, 1039.
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To estimate the dilfusion of gases across the alveolar-eapillary
membrane, one needs to know the partial pressure of the gas
in the alveoli, its partial pressure in the blood, and the volume
of gas transferred from alveoli to blood per minute. A gas
such as carbon monoxide (CO) has a negligible partial pres-
sure in blood.
Two methods exist for estimating CO diffusion: In one,
rebreathing of CO in small concentrations until a steady
state existsm the alveoli, is employed, and in the other a single
breath which is- held for approximately 10 seconds. The
various criticisms which have been applied to these two
methods need not be fully considered here.1 The main difficul-
ties are to obtain a representative alveolar pCO in abnormal
subjects by the first method, and the fact that disappearance
of CO is -not truly exponential in the second method and
that D
L
so calculated tends to decrease with the time of
CO
breathholding.1
The first method seems to be most commonly used, and
results are expressed either (i) as the percentage of CO re-
moved or extracted from inspired gas mixtures, when only the
CO concentrations of inspired and expired gases need be
known, or (ii) as the diffusing capacity of the lungs D ,
L
CO
when in addition to the above measurements, the alveolar
CO concentration, as determined in end-tidal samples, should
be known.
McNamara et al. 2 have already compared these 2 measure-
ments and found that percentage CO extraction and D
L
CO
are both of equal value in differentiating between normal and
abnormal diffusion. They2 also compared these results with
the measurement of conductance of the lung (CL), a term
* This work was carried out in association with the Degenerative
Diseases Group, CSIR.
which they borrowed from Dornhorst. 3 Conductance gives
'an accurate measure of gas transfer from air to pulmonary
capillary blood at the time of the test' and serves 'as an index
of the efficiency of the whole conducting pathway'.2 It does
not however discriminate as effectively between normal
and abnormai diffusion as D or CO% extraction.2
L
CO
The infrared CO analyser gives reliable results in deter-
mining the CO concentrations in the various gases. The
capital outlay required for an infrared CO analyser precludes
this technique from being used in most hospitals, and in
South Africa even the pulmonary physiology units of the
larger teaching hospitals do not have such facilities.
The recent description of a technique by Milledge,4 in
which a pallado-sulphite detector is used for estimating CO
concentration, has made diffusion studies an office procedure.
It also allows such studies to be carried out at the bedside of
severely disabled patients. This technique has been employed
to measure the CO percentage uptake. CO percentage uptake,
however, falls on exercise, while DL and CT> increase as a
larger surface area for diffusion, and an increase in pulmonary
blood flow are established. The fall in CO percentage uptake
on exercise could be explained on the basis of the fact that
ventilation is not taken into account. Hyperventilation in-
creases the volume of gas absorbed, but lowers the percentage
of the gas removed from the inspired air.2 As it is confusing
to express an increased function by a decrease in the deter-
mined values, it seems advisable to use CL when the pallado-
sulphite technique is used for determining diffusion capacity
in exercise studies.
This paper records our experience with Milledge's4 tech-
nique in 18 normal subjects and in patients with emphysema
and fibrosis. The CL was done at rest and during exercise in
normal subjects and in patients, and the results are compared
with those of other workers using an infrared CO analyser.
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METHODS AND MATERIAL
The first few cases were done exactly as described by Milledge.~
Subsequently, a larger bag was used for the inspiratory gas
mixture, and a gasometer has been added to measure the
expired minute volume. Fig. 1 illustrates the apparatus used,
involving a sufficiently large portion of one or both lungs to
show a restrictive abnormality in the lung volumes.
RESULTS
The results of CO percentage uptake are presented in Fig. 2.
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Fig. 1. Diagram of apparatus used. Bags A and Bare 200- and
50-litre Douglas bags.
and the following description refers to the bags A and B as
hown in this diagram.
Bag A is prepared by charging it with 200 litres of oxygen
and approximately 520 ml. of coalgas. The CO concentration
is measured by means of the pallado-sulphite detector and is
approximately O· 04 %. The patient breathes room air through
the two-way taps until accustomed to mouthpiece-breathing
through the one-way valve. The two taps are then tumed so
that the patient inspires from Bag A and expires into bag B
through the gasometer C. After exactly one minute, as timed
on a stopwatch, the taps are closed and the CO concentration
in bag B measured. The gasometer gives the minute volume of
breathing. For exercise studies the same procedure is carried
out after the patient has commenced stepping on a 22 cm.
step at approximately 15 steps per minute. The barometer
reading and temperature are noted.
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Fig. 2. Percentage CO uptake. Results in normal:subjects and
patients with emphysema and fibrosis.
o 0 dyspnoea.
/:::. Grade I dyspnoea.
D Grade IT dyspnoea.
• Grade ill dyspnoea.
The patients' degrees of dyspnoea are indicated. The results
of CL at rest and during exercise in 9 normals and 8 patients
are shown in Fig. 3.
2L.----------------
Fig. 3. Conductance at r t and during exercise in normal
people and patients (same scale applied to both).
CL MVI Fleo -MVE FEeo
Freo (BP-WYP)
where MVI and MVE are the minute volumes (inspiratory
and expiratory respectively) Flea and FEeo are the in-
spired and expired concentrations of CO. BP= barometric
pressure in mm. Hg and WYP=water-vapour pressure at
room temperature. As the difference between MVI and MVE
is small (0'1 litre per 10-20 litres ventilation) the results
are not materially influenced by measuring only the one or
the other,2 in our case MVE.
ine normal male and9normal ffmalesubjects werestudied.
These were members of the resident staff, technicians, typists,
and nurses. All were free from any respiIatory complaints
and most of them had repeated pulmonary-function tests
performed on them, falling within the limits of normal. The
pa tients were referred for pulmonary-function tests and the
diagnosis of emphysema rested on clinical and physiological
data. They ranged from patients with early emphysema to a
severely disabled patient with cor pulmonale.
The patients included under the term 'fibroses' consisted
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ot having an infrared CO analyser, our results are com-
pared with those of other workers using such an analyser.
Our average value for normal subjects (52· 5 %) is simi-
lar to those of Milledge for 14 subjects (52 %). It is also com-
parable to the results obtained on 21 cases (51'1 %) and 10
cases (53' O±2· 24) studied by Mc amara et aP and Bates5
respectively. The last-mentioned two series were studied by
means of an infrared analyser.
ormal persons with an unexpectedly low DJ, or CO per-
centage uptake were found to be hyperventilating in Mc-
amara's2 series, and they co:risider it advisable to state the
ventilation when reporting such values. The ventilation was,
however, not recorded in the 2 normal subjects, with un-
expectedly low values in this study. Fig. 2 also illustrates, as
those of the other workers,3,4 the difference between normal
and abnormal subjects. The general correlation with the
severity of the condition was also demonstrated (Fig. 2).
Our average CL of 8· 54 ml./min.jmrn.Hg compares favour-
ably with that of Mc Tamara et aP (6'5±1'66), and the
average during exercise (14' 5) is comparable to their values
(15' 4± 2· 5) during a comparable exercise load (20 cm. step
at approximately 15 steps per minute).
DISCUSSIO T
Bates6 summarizes the clinical applications of diffusion
studies as follows:
I. Pulmonary emphysema, where the overall diffusing
capacity gives an indication of the state of the lung parenchyma.
This information is not obtained from any of the ventilatory
tests.
2. Obscure pulmonary infiltrations, where the impairment
of diffusion will forecast the alveolar changes that the pathol-
ogist will demonstrate and that the radiologist may have
difficulty in showing.
3. It may be used in the study of cardiopulmonary phe-
nomena such as left ventricular failure, where diffusing
capacity may be a sensitive indicator of change in pulmonary
congestion.
We found this test of value when used in conjunction with
qualitative methods for diffusion capacity (as commonly em-
ployed in the absence of a more specific method for CO
diffusion). Qualitative methods are the estimation of O2
saturation and pC02 in arterial blood. Owing to the fact
that CO2has a greater solubility (and thus diffusion constant)
than O2, impaired diffusion may present as arterial hypoxia
with a normal or low pC02. Probably not always appre-
ciated by the clinician, is the fact that marked ventilation/
perfusion defects can cause the same abnormality, viz.
arterial hypoxia and normal or low arterial pC02 • In lobar
pneumonia, where more than 30 % of the parenchyma is
involved, arterial hypoxia ensues. Because of reduced com-
pliance, the work of breathing increases and the resulting
tachypnoea lowers the pe02 by hyperventilating the normal
70% of lung parenchyma. The functional shunt of blood
through the unventilated consolidated 30% causes hypoxia
which, however, cannot be corrected by the increased ven-
tilation in the normal part of the lung.' Arterial blood-gas
studies (van Slyke for O2 and Astrup method for pC02) are
carried out as a routine on all patients referred to the pulmona-
ry-function laboratory, and arterial hypoxia with normal or
low pC02 may often erroneously be assumed to be pecific
for diffusion defects.
A 'pure' impairment of diffusion, such as may occur in
the Harnman-Rich syndrome, sarcoidosis, etc., does not cause
arterial hypoxia until diffusing capacity is reduced to about
t of normal.1
Rankin1 found diffusing capacity to be one of the most
valuable tests of pulmonary function, while Bates et al.
have concluded that D
L
is the most sel)sitive guide to
- CO
prognosis in emphysema. Mc amara et al., 2 showing that CO
uptake provides 'an estimate of diffusing capacity of the
pulmonary alveoli no matter how the results are expressed'
(i.e. as CO % uptake or D ), make the simplified pro-
Leo
cedure of Milledge4 a mest useful and economic procedure.
An overall accuracy of ± 10% could be obtained in Milledge's
study, as compared to the infrared analyser.
The expendable pallado-sulphite tubes retail at 69c in
South Africa. By using a 200 1. bag a number of tests can be
performed using 2 tubes to check the CO concentration in
the inspiratory bag. We found that this stays the same through-
out the day, but tends to fall if left for longer periods. By
using the tubes from both ends, a duplicate estimate can be
made at a cost of 69c per patient.
If this test is carried out in a large number of patients,
the tests can become expensive. For larger institutions the
choice seems to lie between a small capital outlay and ever-
increasing expendable costs, or a large capital outlay and
relatively low maintenance costs.
OPSOMMING
1. Die ondervinding met 'n eenvoudige sykamer-tegniek
vir CO-diffusie, soos beskryf deur Milledge,4 word bespreek.
Goeie korrelasie is verkry met die resultate van ander ·wer-
kers wat 'n infrarooi eO-analiseerder gebruik. 2 ,5 Daar kan
doeltreffend onderskei word tussen normale en abnormale
persone; ook is 'n bree verhouding tot die graad van dispnee
in die pasiente gevind.
2. 'n Geringe modifikasie van die tegniek word beskryf
om die toets bruikbaar te maak tydens oofeningstudies.
3. Die kliniese waarde van die toots word bespreek.
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